South African billionaire Ivan Saltzman quits Dis-Chem board, ending the founding family's 48-year presence
Ivan Saltzman resigned from the Dis-Chem board with immediate effect, barely three weeks after taking the non-executive seat he retired into.
Ivan Saltzman
Founding family's grip on Dis-Chem loosens as Ivan Saltzman's son quits the board
Saul Saltzman, son of Dis-Chem's billionaire founder Ivan Saltzman, has resigned from the board, loosening the founding family's grip on the retailer.
South Africa has a new dollar billionaire and it is Dis-Chem founder Ivan Saltzman
The Saltzman family has been ranked by the Bloomberg Billionaires Index for the first time with a $1.3 billion fortune built from a single Johannesburg pharmacy.
South African billionaire Ivan Saltzman built Dis-Chem into a $1.7 billion empire but Bloomberg says the succession test is only beginning
Ivan Saltzman built Dis-Chem from a single Johannesburg pharmacy in 1978 into a $1.7 billion healthcare chain and now faces his hardest task: handing it over.
Dis-Chem's new CEO is spending hundreds of millions to reinvent South Africa's biggest pharmacy chain
Dis-Chem CEO Rui Morais is spending hundreds of millions on internal disruption to transform South Africa's second-largest pharmacy chain into an integrated healthcare provider.
South Africa's Human Rights Commission opens hate speech probe into Dis-Chem heir Mark Saltzman
South Africa's Human Rights Commission opened a hate speech investigation into Dis-Chem shareholder Mark Saltzman over posts on X containing the k-word and other racially inflammatory language.
Dis-Chem founders' sons Mark and Dan Saltzman sold $37.9 million in shares months after inheriting a $400 million stake
Mark and Dan Saltzman have sold R642 million ($37.9 million) in Dis-Chem shares months after inheriting a R6.8 billion stake from their parents.
South African multimillionaire Saltzmans gain $20 million in Dis-Chem
South African multimillionaire Saltzman family has gained $20 million as their Dis-Chem stake climbs to $588 million.
South African billionaire Saltzman family’s Dis-Chem stake tops $630 million
The Saltzman family’s Dis-Chem stake tops $630 million after steady JSE gains, signaling cautious investor confidence in pharmacy retail.
Dis-Chem founder Ivan Saltzman to step down from executive board role in 2026
Dis-Chem founder Ivan Saltzman will step back again in 2026, ending an executive era as the family reshapes its shareholding.
South African billionaire Saltzman family’s Dis-Chem posts $1.2 billion half-year revenue
Dis-Chem Pharmacies, backed by South Africa’s billionaire Saltzman family, posted $1.2 billion revenue in H1 2025, driven by retail and wholesale growth.
South Africa’s Saltzman-backed Dis-Chem opens 300th store in Mbombela
Dis-Chem, backed by South Africa’s Saltzman family, has opened its 300th store in Mbombela, expanding access to affordable primary healthcare.
South Africa’s Saltzman family stake in Dis-Chem rebounds to nearly $500 million
The Saltzman family’s stake in Dis-Chem has rebounded to nearly $500 million as shares rally on the Johannesburg Stock Exchange (JSE).
Saltzman family of South Africa sees $28.2 million drop in Dis-Chem stake
Dis-Chem founders lose $28 million as retail stock pressures hit Saltzman family’s holding on the Johannesburg Stock Exchange.
South Africa’s Ivan Saltzman transfers nearly $400 million in Dis-Chem shares to sons
The move involves 217 million shares held via Ivlyn Local Investment Holdings, an investment vehicle controlled by the Saltzman family.
Dis-Chem founder Ivan Saltzman restructures $377.7 million stake among heirs
Dis-Chem’s Ivan Saltzman restructures $377.7 million stake, transferring shares to heirs in a move reinforcing family control, succession, and executive alignment.